Sushmita Konwar
YOU?
Author Swipe
View article: Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins
Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins Open
All approved coronavirus disease 2019 (COVID-19) vaccines in current use are safe, effective, and reduce the risk of severe illness. Although data on the immunological presentation of patients with COVID-19 is limited, increasing experimen…
View article: Potential immune epitope map for structural proteins of SARS-CoV-2
Potential immune epitope map for structural proteins of SARS-CoV-2 Open
Researchers around the world are developing more than 145 vaccines (DNA/mRNA/whole-virus/viral-vector/protein-based/repurposed vaccine) against the SARS-CoV-2 and 21 vaccines are in human trials. However, a limited information is available…